Sclerotherapy is a popular non-invasive procedure used to treat conditions like varicose veins and vascular malformations in the legs. In an effort to provide comprehensive guidance, a group of international experts in the field of phlebology conducted research and developed guidelines to ensure the safe and effective use of sclerotherapy.
The experts identified specific factors that determine a person’s suitability for sclerotherapy. Absolute contraindications, such as hypersensitivity to sclerosing agents, acute venous thromboembolism, severe neurological or cardiac adverse events following previous sclerotherapy, severe illness or infection, and critical limb ischemia, indicate situations where the risks outweigh the potential benefits.
Relative contraindications also exist, where the potential benefits may outweigh the risks or can be minimized with additional measures. These include pregnancy, postpartum and breastfeeding periods, hypercoagulable states with a risk of blood clots, a predisposition to neurological or cardiac adverse events, and poorly controlled chronic systemic illness.
To ensure safe clinical outcomes, healthcare providers must carefully assess patient-related risk factors and engage in open discussions with patients regarding the potential risks and benefits of sclerotherapy. In cases where a person is not a suitable candidate for the procedure, alternative treatment options should be considered and discussed.
Furthermore, the guidelines highlight the importance of well-trained physicians with expertise in phlebology and specialized training in sclerotherapy. These physicians should remain up to date with the latest advancements in medical technology, regularly review and optimize their treatment strategies, and adhere to the evolving scientific evidence.
In conclusion, sclerotherapy is an effective treatment option for lower limb vein conditions. By adhering to the guidelines developed by the international panel of experts, healthcare providers can ensure the safe and effective use of sclerotherapy, minimize complications, and achieve positive patient outcomes. This research and guidelines were published in “Phlebology: The Journal of Venous Disease,” further enhancing their credibility and validity.